BEVERLY, Mass., Aug. 4, 2020 /PRNewswire/ -- Axcelis Technologies, Inc. ACLS today announced financial results for the second quarter ended June 30, 2020.
The Company reported second quarter revenue of $123 million, compared to $119 million for the first quarter of 2020. Operating profit for the quarter was $16.4 million, compared to $13.7 million for the first quarter. Net income for the quarter was $13.3 million, or $0.39 per diluted share, compared to net income for the first quarter of $11.2 million, or $0.33 per diluted share. Gross margin for the quarter was 42.2%, compared to 38.3% in the first quarter. Cash, cash equivalents and restricted cash were $197 million on June 30, 2020, compared to $181.4 million on March 31, 2020.
President and CEO Mary Puma commented, "We are very pleased with our strong second quarter performance. Customer interest in our Purion platform remains strong, as evidenced by demo activity and evaluation system placements for both our Purion base platform and our new Purion product extensions. With the most innovative implant product line available, a broad and diverse customer base, a strong balance sheet and a dedicated team of employees, Axcelis has the building blocks to navigate these uncertain times and ultimately drive growth and market leadership in ion implantation."
Business Outlook
For the third quarter ending September 30, 2020, Axcelis expects revenues to be approximately $110 million with gross margin around 42.5%. Third quarter operating profit is forecasted to be in the range of $10.5-11.5 million with earnings per diluted share of approximately $0.24.
Second Quarter 2020 Conference Call
The Company will host a call to discuss the results for the second quarter 2020 on Wednesday, August 5, 2020 at 8:30 am ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by dialing 866.588.8911 (707.294.1561 outside North America). Participants calling into the conference call will be requested to provide the company name, Axcelis Technologies, and Conference ID: 6153997. Please dial in at least 15 minutes in advance to ensure a timely connection to the call. Webcast replays will be available for 30 days following the call.
Safe Harbor Statement
This press release and the conference call contain forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for spending in our industry and guidance for future financial performance, are based on management's current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.
About Axcelis:
Axcelis ACLS, headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.
Company Contacts
Investor Relations:
Doug Lawson
978.787.9552
Editorial/Media:
Maureen Hart
978.787.4266
Axcelis Technologies, Inc. | |||||||||||||
Consolidated Statements of Operations | |||||||||||||
(In thousands, except per share amounts) | |||||||||||||
(Unaudited) | |||||||||||||
Three months ended | Six months ended | ||||||||||||
June 30, | June 30, | ||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||
Revenue: | |||||||||||||
Product | $ | 117,194 | $ | 68,714 | $ | 229,327 | $ | 152,911 | |||||
Services | 5,771 | 5,591 | 12,629 | 12,871 | |||||||||
Total revenue | 122,965 | 74,305 | 241,956 | 165,782 | |||||||||
Cost of revenue: | |||||||||||||
Product | 65,519 | 37,188 | 132,691 | 84,518 | |||||||||
Services | 5,547 | 5,368 | 11,817 | 12,009 | |||||||||
Total cost of revenue | 71,066 | 42,556 | 144,508 | 96,527 | |||||||||
Gross profit | 51,899 | 31,749 | 97,448 | 69,255 | |||||||||
Operating expenses: | |||||||||||||
Research and development | 16,040 | 13,720 | 30,646 | 27,405 | |||||||||
Sales and marketing | 9,437 | 8,436 | 17,641 | 17,354 | |||||||||
General and administrative | 10,041 | 7,583 | 19,077 | 15,390 | |||||||||
Total operating expenses | 35,518 | 29,739 | 67,364 | 60,149 | |||||||||
Income from operations | 16,381 | 2,010 | 30,084 | 9,106 | |||||||||
Other (expense) income: | |||||||||||||
Interest income | 70 | 845 | 552 | 1,686 | |||||||||
Interest expense | (1,299) | (1,311) | (2,602) | (2,541) | |||||||||
Other, net | 421 | (189) | (199) | (362) | |||||||||
Total other expense | (808) | (655) | (2,249) | (1,217) | |||||||||
Income before income taxes | 15,573 | 1,355 | 27,835 | 7,889 | |||||||||
Income tax provision | 2,271 | 799 | 3,312 | 1,271 | |||||||||
Net income | $ | 13,302 | $ | 556 | $ | 24,523 | $ | 6,618 | |||||
Net income per share: | |||||||||||||
Basic | $ | 0.40 | $ | 0.02 | $ | 0.74 | $ | 0.20 | |||||
Diluted | $ | 0.39 | $ | 0.02 | $ | 0.72 | $ | 0.19 | |||||
Shares used in computing net income per share: | |||||||||||||
Basic weighted average common shares | 33,116 | 32,729 | 32,998 | 32,706 | |||||||||
Diluted weighted average common shares | 33,958 | 33,901 | 34,023 | 34,064 | |||||||||
Axcelis Technologies, Inc. | |||||||
Consolidated Balance Sheets | |||||||
(In thousands, except per share amounts) | |||||||
(Unaudited) | |||||||
June 30, | December 31, | ||||||
2020 | 2019 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 190,340 | $ | 139,881 | |||
Accounts receivable, net | 64,909 | 83,753 | |||||
Inventories, net | 149,178 | 140,364 | |||||
Prepaid expenses and other current assets | 16,272 | 11,681 | |||||
Total current assets | 420,699 | 375,679 | |||||
Property, plant and equipment, net | 27,997 | 25,328 | |||||
Operating lease assets | 5,033 | 5,849 | |||||
Finance lease assets, net | 21,200 | 21,880 | |||||
Long-term restricted cash | 6,676 | 6,653 | |||||
Deferred income taxes | 64,615 | 68,060 | |||||
Other assets | 42,344 | 44,645 | |||||
Total assets | $ | 588,564 | $ | 548,094 | |||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 30,270 | $ | 25,341 | |||
Accrued compensation | 14,221 | 7,631 | |||||
Warranty | 3,942 | 2,759 | |||||
Income taxes | 298 | 294 | |||||
Deferred revenue | 29,181 | 24,601 | |||||
Current portion of finance lease obligation | 654 | 399 | |||||
Other current liabilities | 8,193 | 7,639 | |||||
Total current liabilities | 86,759 | 68,664 | |||||
Long-term finance lease obligation | 47,787 | 48,149 | |||||
Long-term deferred revenue | 1,236 | 4,650 | |||||
Other long-term liabilities | 7,758 | 7,204 | |||||
Total liabilities | 143,540 | 128,667 | |||||
Stockholders' equity: | |||||||
Common stock, $0.001 par value, 75,000 shares authorized; 33,433 shares issued and | 33 | 33 | |||||
Additional paid-in capital | 562,839 | 559,878 | |||||
Accumulated deficit | (117,428) | (140,226) | |||||
Accumulated other comprehensive loss | (420) | (258) | |||||
Total stockholders' equity | 445,024 | 419,427 | |||||
Total liabilities and stockholders' equity | $ | 588,564 | $ | 548,094 | |||
View original content to download multimedia:http://www.prnewswire.com/news-releases/axcelis-announces-financial-results-for-second-quarter-2020-301105927.html
SOURCE Axcelis Technologies, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
